Table 1 Baseline characteristics in each cohort
CAMP | Costa Rica | iCAP | ||
|---|---|---|---|---|
Mean (SD) | ||||
Cases | Controls | |||
N | 711 | 616 | 223 | 858 |
Age | 8.8 (2.1) | 9.0 (1.8) | 25.5 (7.0) | 26.1 (5.3) |
Sex (N, % male) | 416 (59%) | 370 (60%) | 43 (19%) | 136 (16%) |
Baseline post-bronchodilator FEV1 | 1.82 (0.5) | 1.83 (0.5) | ||
baseline post-bronchodilator FEV1 percent-predicted | 104 (12.6) | 104 (16.1) | ||
Baseline post-bronchodilator FVC | 2.15 (0.63) | 2.14 (0.57) | ||
Baseline post-bronchodilator FVC percent-predicted | 107 (12.6) | 109 (15.8) | ||
Post-bronchodilator FEV1 at 4 yr follow up | 2.79 (0.79) | |||
Post-bronchodilator FEV1 at 4 yr follow up percent predicted | 103 (12.6) | |||
Post-bronchodilator FVC at 4 yr follow up | 3.35 (0.98) | |||
Post-bronchodilator FVC at 4 yr follow up percent predicted | 107 (12.2) | |||
rs5743836 C: minor allele T: major allele | ||||
Minor allele frequency | 18% | 10% | 15% | |